HbO2 Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

  • Latest Deal Amount
  • $30M

HbO2 Therapeutics General Information

Description

Developer of human and veterinary hemoglobin-based oxygen carriers designed to help stabilize the patient and prevent tissue damage or organ dysfunction associated with oxygen deprivation. The company's oxygen carriers when intravenously administered, increase the oxygen-carrying capacity of the blood, enabling healthcare providers to treat their patients and improve their quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Corporate Office
  • 674 Souder Road
  • Souderton, PA 18964
  • United States
+1 (267) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HbO2 Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. IPO 26-Apr-2022 $30M Cancelled Generating Revenue
3. Debt - PPP 27-Apr-2020 00000 00.00 Completed Generating Revenue
2. Seed Round 13-Apr-2015 $2.75M $5.5M Completed Generating Revenue
1. Seed Round 13-Mar-2015 $2.75M $2.75M Completed Startup
To view HbO2 Therapeutics’s complete valuation and funding history, request access »

HbO2 Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of human and veterinary hemoglobin-based oxygen carriers designed to help stabilize the patient and prevent ti
Medical Supplies
Souderton, PA
8 As of 2022
00.00
00000000

000000

um dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt
00000000000 0000000
Oceanside, CA
00 As of 0000
0000
00000000 0000

000000

iquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupta
00000 0000000 000 00
Switzerland
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HbO2 Therapeutics Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Advanced Oxygen Therapy Private Debt Financed Oceanside, CA 00 0000 00000000 0000
Hamilton Medical Corporation Switzerland
You’re viewing 2 of 2 competitors. Get the full list »

HbO2 Therapeutics Patents

HbO2 Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3143968-A1 Hemoglobin substitute mixtures including reconstituted plasma and platelets and their manufacture and use Pending 02-Jul-2019 000000000
AU-2020331892-A1 Hemoglobin substitute mixtures including reconstituted plasma and platelets and their manufacture and use Pending 02-Jul-2019 000000000
US-20220354930-A1 Hemoglobin substitute mixtures including reconstituted plasma and platelets and their manufacture and use Pending 02-Jul-2019 0000000000
US-20140227677-A1 Perfusion of prospective donor hearts with polymerized hemoglobin Inactive 07-Feb-2013 0000000000 0
US-20200060260-A1 Compositions and methods for organ preservation Inactive 12-Oct-2012 A01N1/0226
To view HbO2 Therapeutics’s complete patent history, request access »

HbO2 Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Zafiris Zafirelis Co-Founder, Co-Chief Executive Officer, President & Board Member
Igor Serov Chief Financial Officer
Joseph Rappold MD Chief Medical Officer
You’re viewing 3 of 4 executive team members. Get the full list »

HbO2 Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HbO2 Therapeutics FAQs

  • When was HbO2 Therapeutics founded?

    HbO2 Therapeutics was founded in 2014.

  • Who is the founder of HbO2 Therapeutics?

    Gerald Kowalski and Zafiris Zafirelis are the founders of HbO2 Therapeutics.

  • Who is the CEO of HbO2 Therapeutics?

    Zafiris Zafirelis is the CEO of HbO2 Therapeutics.

  • Where is HbO2 Therapeutics headquartered?

    HbO2 Therapeutics is headquartered in Souderton, PA.

  • What is the size of HbO2 Therapeutics?

    HbO2 Therapeutics has 8 total employees.

  • What industry is HbO2 Therapeutics in?

    HbO2 Therapeutics’s primary industry is Medical Supplies.

  • Is HbO2 Therapeutics a private or public company?

    HbO2 Therapeutics is a Private company.

  • What is HbO2 Therapeutics’s current revenue?

    The current revenue for HbO2 Therapeutics is 000000.

  • How much funding has HbO2 Therapeutics raised over time?

    HbO2 Therapeutics has raised $5.5M.

  • Who are HbO2 Therapeutics’s competitors?

    Advanced Oxygen Therapy and Hamilton Medical are competitors of HbO2 Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »